DSC3 and breast carcinoma: Cancer development and progression are associated with either loss of DSC3 expression, as seen in prostate or breast cancer, or overexpression of DSC3 including its cytoplasmic expression as seen with squamous non-small-cell lung cancer and colorectal cancer [2,4].